# Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

> **NCT02097004** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 111 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **BIOLOGICAL:** Peginterferon alfa-2a
- **BIOLOGICAL:** HBV vaccination
- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT02097004
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2018-01
- **Final completion:** 2018-03-13
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097004, "Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02097004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*